Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of.

Slides:

Advertisements

Similar presentations

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

Advertisements

Doxycycline for outpatient-treated acute exacerbations of COPD: a randomised double- blind placebo-controlled trial Patricia van Velzen, MD, Gerben ter.

Volume 355, Issue 9212, Pages (April 2000)

Volume 379, Issue 9824, Pages (April 2012)

Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes.

Volume 357, Issue 9257, Pages (March 2001)

Volume 8, Issue 10, Pages (October 2009)

Volume 11, Issue 4, Pages (April 2012)

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised.

Melody Sherwood, Peter A McCullough The Lancet Global Health

Volume 16, Issue 9, Pages (September 2015)

Volume 376, Issue 9734, Pages (July 2010)

Volume 17, Issue 2, Pages (February 2016)

Volume 373, Issue 9679, Pages (June 2009)

Thank God for Richard Dawkins?

Long-term effects of hormone replacement therapy

Fetal growth and ethnic variation

Meta-analysis of randomised controlled trials

Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment

Low-level laser therapy for neck pain

Understanding EMPA-REG OUTCOME

Volume 376, Issue 9734, Pages (July 2010)

Volume 392, Issue 10145, Pages (August 2018)

Long-term effects of hormone replacement therapy

Body-mass index and all-cause mortality – Authors' reply

Volume 373, Issue 9677, Pages (May 2009)

Aspirin in the prevention of cancer – Author's reply

Correction to Lancet Diabetes Endocrinol 2015; 3: 263–74

Diabetes and risk of physical disability in adults: a systematic review and meta-analysis Dr Evelyn Wong, MBBS, Kathryn Backholer, PhD, Emma Gearon, BBioMedSc,

Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:

Volume 373, Issue 9679, Pages (June 2009)

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised.

Volume 372, Issue 9642, Pages (September 2008)

Melody Sherwood, Peter A McCullough The Lancet Global Health

Understanding EMPA-REG OUTCOME

Volume 382, Issue 9888, Pages (July 2013)

Incident diabetes in clinical trials of antihypertensive drugs

Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK Krishnan Bhaskaran, PhD,

Mortality risk with dual antiplatelet therapy?

Meta-analysis of randomised controlled trials

Arnaud Chiolero The Lancet Public Health

Statin use before diabetes diagnosis and risk of microvascular disease: a nationwide nested matched study Sune F Nielsen, PhD, Prof Børge G Nordestgaard,

Late-stage research for diabetes and related NCDs receives little funding: evidence from the NIH RePORTER tool Pascal Geldsetzer, Till Bärnighausen

Volume 381, Issue 9875, Pages (April 2013)

Ngoc Minh Pham, Chung Thanh Nguyen, Colin W Binns, Andy H Lee

Correction to Lancet Diabetes Endocrinol 2015; 3: 263–74

Volume 375, Issue 9709, Pages (January 2010)

Confessions of a journal junkie

Volume 371, Issue 9627, Pages (May 2008)

Volume 378, Issue 9786, Pages (July 2011)

Telling it like it isn't: truth and lies in a post-9/11 world

Thank God for Richard Dawkins?

Volume 373, Issue 9658, Pages (January 2009)

Volume 375, Issue 9719, Pages (March 2010)

Does midlife obesity really lower dementia risk?

Muh Geot Wong, Vlado Perkovic The Lancet Diabetes & Endocrinology

ACST: which subgroups will benefit most from carotid endarterectomy?

Volume 383, Issue 9921, Pages (March 2014)

Fetal growth and ethnic variation

Methods for guideline development

The Lancet Diabetes & Endocrinology

Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28.

Volume 368, Issue 9541, Pages (September 2006)

Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised.

Vitamin D in chronic kidney disease: is the jury in?

This Month in AJKD American Journal of Kidney Diseases

Clinic attendance and disengagement of young adults with type 1 diabetes after transition of care from paediatric to adult services (TrACeD): a randomised,

Volume 17, Issue 2, Pages (February 2016)

Symptom-based stratification of autoimmune diseases

Reversible biological adaptations in obesity

Presentation transcript:

Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial The Lancet Diabetes & Endocrinology Volume 2, Issue 10, Pages 801-809 (October 2014) DOI: 10.1016/S2213-8587(14)70156-1 Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 1 Trial profile CKD=chronic kidney disease. The Lancet Diabetes & Endocrinology 2014 2, 801-809DOI: (10.1016/S2213-8587(14)70156-1) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 2 Cumulative incidence of very-high-risk chronic kidney disease Too few observations were available beyond year 10 for reliable estimates. The Lancet Diabetes & Endocrinology 2014 2, 801-809DOI: (10.1016/S2213-8587(14)70156-1) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 3 Subgroup analyses of first occurrence of very-high-risk chronic kidney disease and incidence rates The dotted reference line refers to the overall HR. DSE=diabetes support and education group. HR=hazard ratio. ILI=intensive lifestyle intervention group. *For the tests of interaction between the subgroups and the intervention group. The Lancet Diabetes & Endocrinology 2014 2, 801-809DOI: (10.1016/S2213-8587(14)70156-1) Copyright © 2014 Elsevier Ltd Terms and Conditions